![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...
EDISON, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial intelligence assisted therapeutic...
EDISON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (โAIโ)-driven...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -18.1818181818 | 1.1 | 1.1 | 0.96 | 10455 | 1.02290162 | CS |
4 | -0.18 | -16.6666666667 | 1.08 | 1.22 | 0.9 | 20950 | 1.06525293 | CS |
12 | -1.34 | -59.8214285714 | 2.24 | 2.24 | 0.9 | 35344 | 1.33367106 | CS |
26 | -2.21 | -71.0610932476 | 3.11 | 3.4899 | 0.9 | 55975 | 2.00372617 | CS |
52 | -8.95 | -90.8629441624 | 9.85 | 11.07 | 0.9 | 51531 | 3.13169893 | CS |
156 | -38.9 | -97.7386934673 | 39.8 | 40.92 | 0.9 | 397598 | 22.63734455 | CS |
260 | -61.3 | -98.5530546624 | 62.2 | 167 | 0.9 | 984492 | 45.69126046 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions